Developing Multi-Targeted T-Cell Engagers With Deck Bio's Johanna Kaufmann
Source: Bioprocess Online
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Deck Bio’s CSO, Johanna Kaufmann, to discuss the company’s multi-peptide-MHC-targeted T-cell engager platform for solid tumors.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online